Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Saravana Kumar Ramasubbu
Observed name:
SaravanaKumar Ramasubbu
Institutions:
All India Institute of Medical Sciences, Madurai,
All India Institute of Medical Sciences
Observed institutions:
All India Institute of Medical Sciences Rishikesh,
All India Institute of Medical Sciences, Kalyani,
All India Institute of Medical Sciences, Madurai,
All India Institute of Medical Sciences,
Amrita Vishwa Vidyapeetham
ORCID:
0000-0002-5449-3467
Observed ORCID:
0000-0002-5449-3467
OpenAlex ID:
A5038058630
Quality of life and factors affecting it in adult cancer patients undergoing cancer chemotherapy in a tertiary care hospital
2020
·
Saravana Kumar Ramasubbu
, Rajesh K. Pasricha
, et al.
·
Cancer Reports
·
129
PDF
Leading 20 drug–drug interactions, polypharmacy, and analysis of the nature of risk factors due to QT interval prolonging drug use and potentially inappropriate psychotropic use in elderly psychiatry outpatients
2021
·
Biswadeep Das
, Saravana Kumar Ramasubbu
, et al.
·
Therapeutic Advances in Cardiovascular Disease
·
37
Prevalence, severity, and nature of risk factors associated with drug-drug interactions in geriatric patients receiving cancer chemotherapy: A prospective study in a tertiary care teaching hospital
2020
·
Saravana Kumar Ramasubbu
, Sumit Kumar Mahato
, et al.
·
Cancer Treatment and Research Communications
·
25
Frequency, characteristics and nature of risk factors associated with use of QT interval prolonging medications and related drug-drug interactions in a cohort of psychiatry patients
2019
·
Biswadeep Das
, Vikram Singh Rawat
, et al.
·
Therapies
·
24
Frequency, nature, severity and preventability of adverse drug reactions arising from cancer chemotherapy in a teaching hospital
2020
·
Saravana Kumar Ramasubbu
, Rajesh K. Pasricha
, et al.
·
Journal of Family Medicine and Primary Care
·
20
Top 20 drug − drug interactions, polypharmacy and analysis of the nature of risk factors due to QT interval prolonging drug use in elderly psychiatry outpatients
2020
·
Biswadeep Das
, SaravanaKumar Ramasubbu
, et al.
·
Journal of Family Medicine and Primary Care
·
17
Prevalence of QT-Prolonging Drug-Drug Interactions in Psychiatry: A Systematic Review and Meta Analysis
2022
·
Saravana Kumar Ramasubbu
, Archana Mishra
, et al.
·
Journal of Pharmacy Practice
·
13
Prevalence, Attributes, and Risk Factors of QT-Interval-Prolonging Drugs and Potential Drug-Drug Interactions in Cancer Patients: A Prospective Study in a Tertiary Care Hospital
2024
·
Akash Agnihotri
, Saravana Kumar Ramasubbu
, et al.
·
Cureus
·
11
Therapeutic Drug-Drug Interactions (DDIs) Causing QT Prolongation in Patients With Cancer: A Systematic Review and Meta-Analysis
2025
·
Saravana Kumar Ramasubbu
, Archana Mishra
, et al.
·
Cureus
·
6
PDF
Rimegepant: first novel oral calcitonin gene-related peptide inhibitor for migraine
2020
·
Saravana Kumar Ramasubbu
, Senkadhirdasan Dakshinamurthy
, et al.
·
International Journal of Basic & Clinical Pharmacology
·
2
PDF
Systematic Review of Neuropsychiatric Side Effects Induced by Mefloquine: Evidence From Case Reports and Clinical Studies
2026
·
Saravana Kumar Ramasubbu
, Ann George
, et al.
·
Cureus
Potential drug-drug interaction prevalence and risk factors associated with QT interval prolonging psychotropic use in children and adolescents
2021
·
Biswadeep Das
, Vikram Singh Rawat
, et al.
·
Progress in Pediatric Cardiology
Show more works
View as search
Works count:
12
Citation count:
284
H-index:
8
I10-index:
8
Year
Topic
Type